TSH Biopharm Corporation Limited (TPEX:8432)

TSH Biopharm Corporation Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	507.63	588.34	576.59	488.9	381.89	396.7
Short-Term Investments	54.84	309.02	195.54	326.86	351.52	328.97
Cash & Short-Term Investments	562.46	897.36	772.12	815.77	733.41	725.67
Cash Growth	-40.83%	16.22%	-5.35%	11.23%	1.07%	6.31%
Accounts Receivable	234.9	211.68	208.33	202.55	99.07	108.88
Other Receivables	2.56	2.39	2.18	1.83	1.06	2.98
Receivables	237.46	214.07	210.51	204.38	100.13	111.86
Inventory	183.16	176.08	118.4	107.39	73.22	77.91
Prepaid Expenses	15.56	16.79	9.29	-	-	-
Other Current Assets	333.58	0.41	3.44	15.37	13.22	28.41
Total Current Assets	1,332	1,305	1,114	1,143	919.97	943.84
Property, Plant & Equipment	39.91	40.41	32.68	41.64	27.36	34.04
Long-Term Investments	190.24	192.63	188.89	179.08	212.06	241.43
Goodwill	-	247.9	-	-	-	-
Other Intangible Assets	295.87	39.75	53.64	64.07	3.63	6.18
Long-Term Deferred Tax Assets	4.01	4.01	1.51	1.8	2.01	1.26
Other Long-Term Assets	15.5	12.78	9.39	5.62	4.39	2.64
Total Assets	1,878	1,842	1,400	1,435	1,169	1,229
Accounts Payable	89.37	71.36	51.42	57.64	12.72	7.42
Accrued Expenses	-	56.69	35.21	37.4	44.77	48.8
Short-Term Debt	-	-	-	20	-	-
Current Portion of Long-Term Debt	-	-	-	18.85	-	-
Current Portion of Leases	10.5	10.1	7.4	7.32	4.57	4.37
Current Income Taxes Payable	41.63	32.23	2.97	8.02	7.1	15.65
Current Unearned Revenue	1.64	1.04	1.84	5.43	-	-
Other Current Liabilities	84.09	37.48	34.79	50.85	16.64	22.39
Total Current Liabilities	227.23	208.9	133.63	205.5	85.8	98.62
Long-Term Debt	-	-	-	9.6	-	-
Long-Term Leases	-	10.33	-	7.36	-	4.42
Total Liabilities	236.8	219.23	133.63	222.46	85.8	103.04
Common Stock	383.98	383.98	383.98	383.98	383.98	383.98
Additional Paid-In Capital	459.55	459.55	459.5	459.44	459.36	458.98
Retained Earnings	511.09	480.68	204.14	228.37	224.08	266.63
Comprehensive Income & Other	49.62	67.58	59.98	22.58	16.21	16.76
Total Common Equity	1,404	1,392	1,108	1,094	1,084	1,126
Minority Interest	236.72	231.18	158.63	118.31	-	-
Shareholders' Equity	1,641	1,623	1,266	1,213	1,084	1,126
Total Liabilities & Equity	1,878	1,842	1,400	1,435	1,169	1,229
Total Debt	10.5	20.43	7.4	63.13	4.57	8.78
Net Cash (Debt)	551.96	876.93	764.73	752.64	728.84	716.89
Net Cash Growth	-41.60%	14.67%	1.60%	3.27%	1.67%	5.68%
Net Cash Per Share	14.35	22.81	19.90	19.57	18.96	18.65
Filing Date Shares Outstanding	38.5	38.4	38.4	38.4	38.4	38.4
Total Common Shares Outstanding	38.5	38.4	38.4	38.4	38.4	38.4
Working Capital	1,105	1,096	980.13	937.41	834.17	845.22
Book Value Per Share	36.48	36.25	28.85	28.50	28.22	29.33
Tangible Book Value	1,108	1,104	1,054	1,030	1,080	1,120
Tangible Book Value Per Share	28.79	28.76	27.45	26.83	28.13	29.17
Land	-	5.85	5.85	5.85	5.85	5.85
Buildings	-	14.2	14.2	13.94	13.94	13.94
Machinery	-	47.68	33.13	31.41	22.48	22.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.